0.2052
price down icon11.31%   -0.0262
pre-market  Pre-mercato:  .22   0.0149   +7.24%
loading

Genprex Inc Azioni (GNPX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
1.59%
2.4995
2.54 2.8385 2.7561 1.6665
Costs And Expenses
17.95%
4.6818
3.9693 4.3357 4.3234 6.5183
Operating Income/Loss
17.95%
-4.6818
-3.9693 -4.3357 -4.3234 -6.5183
Income/Loss From Continuing Operations Before Tax
18.09%
-4.6818
-3.9646 -4.3357 -4.3234 -6.4958
Income/Loss From Continuing Operations After Tax
17.92%
-4.6749
-3.9646 -4.3305 -4.316 -6.4958
Net Income/Loss
17.92%
-4.6749
-3.9646 -4.3305 -4.316 -6.4958
Preferred Stock Dividends And Other Adjustments
-
- 0.2771 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
80.76%
27.59
15.27 1.5743 3.4998 2.162
Basic Earnings Per Share
34.62%
-0.17
-0.26 1.56 -1.23 -3.00
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- 0.2771 - -
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Capitalizzazione:     |  Volume (24 ore):